4-(6-{[(4-chlorophenyl)sulfanyl]methyl}-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine

Catalog No. :
ACUJXB152
CAS No. :
338960-30-8
Molecular Formula :
C18H22ClN3OS
Molecular Weight :
363.91

IUPAC Name:4-(6-(((4-chlorophenyl)thio)methyl)-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine

4-(6-{[(4-chlorophenyl)sulfanyl]methyl}-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(6-{[(4-chlorophenyl)sulfanyl]methyl}-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine
IUPAC Name4-(6-(((4-chlorophenyl)thio)methyl)-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine
Molecular FormulaC18H22ClN3OS
Molecular Weight363.91
SMILESCC1OC(C)CN(C2=NC(C)=NC(CSC3=CC=C(Cl)C=C3)=C2)C1
InChI KeyAHOLCSNBDHKBQQ-UHFFFAOYSA-N
Synonym4-(6-([(4-CHLOROPHENYL)SULFANYL]METHYL)-2-METHYL-4-PYRIMIDINYL)-2,6-DIMETHYLMORPHOLINE;4-CHLOROPHENYL [6-(2,6-DIMETHYLMORPHOLINO)-2-METHYL-4-PYRIMIDINYL]METHYL SULFIDE;4-(6-{[(4-chlorophenyl)sulfanyl]methyl}-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine;Morpholine, 4-[6-[[(4-chlorophenyl)thio]methyl]-2-methyl-4-pyrimidinyl]-2,6-dimethyl-
CAS No.338960-30-8

Synthetic Route by SureRoute

1. ACUJXB152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUJXB152 route product structure diagram
    ACUJXB152338960-30-8
Inquiry

2. ACUJXB152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTPO970 route compound structure diagram
    ACBTPO97080567-00-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUJXB152 route product structure diagram
    ACUJXB152338960-30-8
Inquiry

Comments (0)